NuCana
Utility Patent Applications
Last updated:
List of all NuCana patents 22 in total
Status | Patent |
---|---|
Application | Utility: FORMULATION COMPRISING A GEMCITABINE-PRODRUG Filling date: 7 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: PROCESS FOR PREPARING NUCLEOSIDE PRODRUGS Filling date: 7 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS Filling date: 7 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER COMPOUNDS Filling date: 7 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: CRYSTALLINE FORM OF GEMCITABINE Filling date: 7 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER COMPOUNDS Filling date: 7 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS Filling date: 7 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS Filling date: 7 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES Filling date: 7 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: FORMULATION COMPRISING A GEMCITABINE-PRODRUG Filling date: 7 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: Treatment Regimens Filling date: 7 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: COMBINATION THERAPY FOR CANCER Filling date: 7 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: GEMCITABINE PRODRUGS Filling date: 7 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: FLOXURIDINE SYNTHESIS Filling date: 7 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Combination Therapy Filling date: 7 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS Filling date: 7 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: SYNTHESIS OF 3'-DEOXYADENOSINE-5'-O-[PHENYL(BENZYLOXY-L-ALANINYL)]PHOSPHATE (NUC-7738) Filling date: 7 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: SYNTHESIS OF PHOSPHATE DERIVATIVES Filling date: 7 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS Filling date: 7 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: CANCER TREATMENTS Filling date: 7 Sep 2025 Issue date: 12 Dec 2019 |
Showing 1 to 22 of 22 patents.